Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms.

McCann UD, Ricaurte GA.

ScientificWorldJournal. 2007 Nov 2;7:231-8. Review.

3.

Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.

Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G.

Psychopharmacology (Berl). 2004 May;173(3-4):296-309. Epub 2004 Apr 9.

PMID:
15083265
4.

Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.

Allen RP, McCann UD, Ricaurte GA.

Sleep. 1993 Sep;16(6):560-4.

PMID:
7901886
5.

MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.

Gyongyosi N, Balogh B, Kirilly E, Kitka T, Kantor S, Bagdy G.

Brain Res. 2008 Sep 22;1231:34-46. doi: 10.1016/j.brainres.2008.06.099. Epub 2008 Jul 2.

PMID:
18638459
6.

MDMA alters the response of the circadian clock to a photic and non-photic stimulus.

Colbron S, Jones M, Biello SM.

Brain Res. 2002 Nov 22;956(1):45-52.

PMID:
12426045
7.
8.

Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.

McCann UD, Edwards RR, Smith MT, Kelley K, Wilson M, Sgambati F, Ricaurte G.

Psychopharmacology (Berl). 2011 Oct;217(4):475-84. doi: 10.1007/s00213-011-2303-7. Epub 2011 May 21.

PMID:
21603895
10.

MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro.

Biello SM, Dafters RI.

Brain Res. 2001 Nov 30;920(1-2):202-9.

PMID:
11716826
11.

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.

McCann UD, Eligulashvili V, Ricaurte GA.

Neuropsychobiology. 2000;42(1):11-6. Review.

PMID:
10867551
12.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Ricaurte GA, McCann UD, Szabo Z, Scheffel U.

Toxicol Lett. 2000 Mar 15;112-113:143-6. Review.

PMID:
10720723
13.
14.

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.

J Psychopharmacol. 2006 May;20(3):389-99.

PMID:
16574713
15.
16.

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

Steele TD, McCann UD, Ricaurte GA.

Addiction. 1994 May;89(5):539-51. Review.

PMID:
7913850
17.

Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment.

Gyongyosi N, Balogh B, Katai Z, Molnar E, Laufer R, Tekes K, Bagdy G.

J Neural Transm (Vienna). 2010 Mar;117(3):285-92. doi: 10.1007/s00702-009-0357-z. Epub 2010 Jan 6.

PMID:
20052506
18.

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

Clemens KJ, McGregor IS, Hunt GE, Cornish JL.

Drug Alcohol Rev. 2007 Jan;26(1):9-15. Review.

PMID:
17364831
19.

Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.

Meyer JS, Piper BJ, Vancollie VE.

Ann N Y Acad Sci. 2008 Oct;1139:151-63. doi: 10.1196/annals.1432.029.

PMID:
18991859
20.

Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Capela JP, Fernandes E, Remião F, Bastos ML, Meisel A, Carvalho F.

Neurotoxicology. 2007 Jul;28(4):868-75. Epub 2007 Apr 27.

PMID:
17572501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk